GLP-1 drug users have significantly more retained gastric contents on EGD, but patients who undergo same-day colonoscopy (with bowel prep) have reduced retained gastric content risk—suggesting colonoscopy prep serves as effective gastric preparation.
Same-day colonoscopy = solutionColonoscopy bowel preparation also empties the stomach—reducing GLP-1 drug-associated retained gastric content and providing a practical management strategy for endoscopy safety
What the researchers found
GLP-1 drug users: significantly ↑retained gastric contents on EGD. Same-day colonoscopy: ↓retained gastric content risk. Colonoscopy bowel prep: effectively empties stomach. Practical solution identified.
Why it matters
This provides a practical solution: when GLP-1 drug users need upper endoscopy, scheduling a same-day colonoscopy (with its bowel preparation) effectively prepares the stomach too.
How the study worked
Retrospective analysis of retained gastric contents during EGD in GLP-1RA users. Comparison: EGD alone vs same-day EGD + colonoscopy.
What this study cannot tell us
Retrospective. Cannot determine optimal preparation protocol. Sample sizes in full study. Not all patients need colonoscopy.
How to read the evidence
Retrospective analysis with practical clinical finding.
When this study was published
Published in 2025.
The bigger picture
Rather than canceling or delaying procedures for GLP-1 drug users, scheduling same-day colonoscopy provides both procedures while addressing the gastric content concern through bowel preparation.
Questions still open
- Should all GLP-1 users have colonoscopy-grade prep before EGD?
- Would a clear liquid diet alone be sufficient?
- Is the aspiration risk truly reduced with bowel prep?
Common questions
Is it safe to have an endoscopy while on GLP-1 drugs?
Do I need to stop my GLP-1 drug before endoscopy?
Read the original research
GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk.
Frontiers in medicine, 12, 1638981
Citation
Ukwade, Dirin; Hernandez, Luis J; Modi, Zeel; Raza, Hasan S; Siegel, Michael; Nwachukwu, Dexter; Sarraf, Paya; Memon, Abdullah; Booth, Marya; Cooper, Karen; Boulay, Brian R; Mutlu, Ece A. (2025). GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk.. Frontiers in medicine, 12, 1638981. https://doi.org/10.3389/fmed.2025.1638981